Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-small Cell Lung Cancer Metastatic 1

Interventions

Cisplatin 508 Cyclophosphamide 360 Carboplatin 352 Radiotherapy 350 Capecitabine 328 Paclitaxel 324 Oxaliplatin 323 Gemcitabine 320 Docetaxel 310 Fluorouracil 282 Drug Therapy 243 apatinib 242 Bevacizumab 228 camrelizumab 214 Etoposide 200 Irinotecan 175 Doxorubicin 175 Leucovorin 161 Dexamethasone 160 sintilimab 142 pembrolizumab 138 Pemetrexed 136 Cytarabine 136 anlotinib 135 toripalimab 130 Neoadjuvant Therapy 122 S 1 (combination) 120 Vincristine 119 Rituximab 116 Radiosurgery 116

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × GC Temporary Stopping × Clear all

NCT06127940 2023-11-13

K-SAB

Karolinska University Hospital

Phase 1 Unknown

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡